Literature DB >> 22920075

Clinical, biochemical, and genetic characterization of type III hereditary angioedema in 13 Northwest Spanish families.

Carmen Marcos1, Alberto López Lera, Susana Varela, Tania Liñares, Marimar G Alvarez-Eire, Margarita López-Trascasa.   

Abstract

BACKGROUND: A new variant of hereditary angioedema has been reported during the last decade. Three main characteristics distinguish it from classic hereditary angioedema: normal C1 inhibitor activity, predominance in women, and different genetic alterations.
OBJECTIVE: To assess the symptoms, laboratory findings, and treatment of a population with type III hereditary angioedema from Northwest Spain.
METHODS: We studied 29 patients (26 female and 3 male) from 13 different families.
RESULTS: The 26 female patients showed a similar clinical pattern to the classic forms of hereditary angioedema, and 22 of these patients had the estrogen-dependent phenotype. Three patients had a negative family history, and 1 of the parents was confirmed as an asymptomatic carrier in 2 of them. All had functional C1 inhibitor activity within the normal range in periods without high estrogen levels, but during attacks (in female patients) and pregnancy, activity decreased to below 50%. One male patient had normal C1 inhibitor activity during attacks, and he was initially diagnosed as having idiopathic angioedema. The C4 and antigenic C1 inhibitor levels were always normal. All studied patients had the c.1032C>A, Thr309Lys mutation in the factor XII gene. The mutation was also found in asymptomatic relatives: 5 of 6 men studied and 1 of 8 women studied.
CONCLUSION: Positive family history is a diagnosis criterion, but it could be lacking because there may be asymptomatic relatives, primarily males.
Copyright © 2012 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22920075     DOI: 10.1016/j.anai.2012.05.022

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  10 in total

1.  Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III.

Authors:  Jenny Björkqvist; Steven de Maat; Urs Lewandrowski; Antonio Di Gennaro; Chris Oschatz; Kai Schönig; Markus M Nöthen; Christian Drouet; Hal Braley; Marc W Nolte; Albert Sickmann; Con Panousis; Coen Maas; Thomas Renné
Journal:  J Clin Invest       Date:  2015-07-20       Impact factor: 14.808

2.  The FXII c.-4T>C Polymorphism as a Disease Modifier in Patients With Hereditary Angioedema Due to the FXII p.Thr328Lys Variant.

Authors:  Fernando Corvillo; María Eugenia de la Morena-Barrio; Carmen Marcos-Bravo; Margarita López-Trascasa; Vicente Vicente; Jonas Emsley; Teresa Caballero; Javier Corral; Alberto López-Lera
Journal:  Front Genet       Date:  2020-09-10       Impact factor: 4.599

Review 3.  Managing the female patient with hereditary angioedema.

Authors:  Aleena Banerji; Marc Riedl
Journal:  Womens Health (Lond)       Date:  2016-03-15

Review 4.  Differential Diagnosis and Management Issues of Idiopathic Angiooedema and their Resolution.

Authors:  Andrea Zanichelli; Marta Mansi; Maddalena A Wu; Giulia Azin; Marco Cicardi
Journal:  J Crit Care Med (Targu Mures)       Date:  2015-06-05

Review 5.  Leveraging Genetics for Hereditary Angioedema: A Road Map to Precision Medicine.

Authors:  Anastasios E Germenis; Matija Rijavec; Camila Lopes Veronez
Journal:  Clin Rev Allergy Immunol       Date:  2021-01-28       Impact factor: 8.667

6.  Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant.

Authors:  Laurence Bouillet; Isabelle Boccon-Gibod; David Launay; Anne Gompel; Gisele Kanny; Vincent Fabien; Oliver Fain
Journal:  Immun Inflamm Dis       Date:  2017-01-11

7.  Clinical profile and treatment outcomes in patients with hereditary angioedema with normal C1 esterase inhibitor.

Authors:  Douglas H Jones; Priya Bansal; Jonathan A Bernstein; Shahnaz Fatteh; Joseph Harper; F Ida Hsu; Maeve O'Connor; Nami Park; Daniel Suez
Journal:  World Allergy Organ J       Date:  2022-01-27       Impact factor: 4.084

8.  Pregnancy in Patients With Hereditary Angioedema and Normal C1 Inhibitor.

Authors:  Natalia Gabriel; Fernanda Marcelino; Mariana P L Ferriani; L Karla Arruda; Regis A Campos; Rozana F Gonçalves; Herberto Chong-Neto; Nelson Rosario Filho; Solange O R Valle; Joao B Pesquero; Anete S Grumach
Journal:  Front Allergy       Date:  2022-02-17

Review 9.  Management of hereditary angioedema in pregnant women: a review.

Authors:  Teresa Caballero; Julio Canabal; Daniela Rivero-Paparoni; Rosario Cabañas
Journal:  Int J Womens Health       Date:  2014-09-09

10.  Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence.

Authors:  Konrad Bork; Thomas Machnig; Karin Wulff; Guenther Witzke; Subhransu Prusty; Jochen Hardt
Journal:  Orphanet J Rare Dis       Date:  2020-10-15       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.